In Osteosarcoma and renal cell carcinoma, UBE2T overexpression increased the capacity of proliferation via PI3K/AKT pathway [17, 32], and was associated with aggressiveness, metastasis and poor prognosis [13, 18, 33, 34]. The gene discussed is UBE2T; the disease is osteosarcoma.